OPRM1 and neoplasm: Although most of the research results revealed that the activated MOR could promote tumor progression, for patients with advanced tumors, the effect of the MOR agonist on the opioid receptor in the central nervous system could effectively relieve their pains, reduce inflammatory reactions caused by tumors, inhibit angiogenesis, and alleviate tumor recurrence and metastasis (78).